Brock Reeve, Executive Director of the Harvard Stem Cell Institute, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âTaking technology from the lab to the market: assessing commercialization business models.'
In his presentation, Brock gives an overview on:
- Who has the right motivation and capability to commercialize? What's the best organizational structure?
- Who funds it? Who controls the IP?
- How to de-risk the science to successfully translate academic research into the market.
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.